Skip to main content
Kane Biotech
Global Pandemic
Biofilm R+D
Understanding Biofilms
Biofilm – Problem Areas
Our Facilities
Glossary of Terms
Sources
Technologies
Human Health
Animal Health
Industrial
About
About Us
Our Team
Awards
Careers
Investors
Overview
News / Events
Company Information
Financial Results
Stock Data
SEDAR
Corporate Governance
Contact
Press Releases
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.
Investors
Overview
News / Events
Press Releases
IR Calendar
Email Alerts
Company Info
Profile
Presentations
Management Team
Contacts
FAQ
Financial Results
Stock Data
TSX-V:KNE
OTCQB:KNBIF
SEDAR
Governance
Board of Directors
Board Committees
Governance Documents
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
News / Events
Press Releases
IR Calendar
Email Alerts
All News
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Kane Biotech Launches Four New bluestem™ Products
Dec 12, 2018
Kane Biotech Announces Third Quarter 2018 Financial Results
Nov 14, 2018
Kane Biotech Announces Extension of Warrants
Nov 12, 2018
Kane Biotech Records Significant Online Sales Growth from Amazon
Nov 9, 2018
Kane Biotech Schedules Third Quarter 2018 Earnings Conference Call and Business Update
Nov 8, 2018
Kane Biotech Senior Management Purchases 1.9 Million Shares
Nov 7, 2018
Kane Biotech Appoints Dr. Gordon Guay as Chief Scientific Officer
Nov 5, 2018
Kane Biotech Announces New Manufacturing Partner for bluestem™ Product Line
Oct 17, 2018
Kane Biotech Announces Formation of Scientific Advisory Board
Sep 24, 2018
Kane Biotech Announces Departure of CEO
Sep 11, 2018
1
2
3
4
5
6
7
8
9
10
...21
